In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Leveraging FDA Fast Track and Accelerated Approval pathways Consultants can reduce drug development timelines by leveraging ... streamlining the regulatory process. Engagement with Contract ...

Based on Intelligencia AI’s comprehensive, proprietary database of over 20,000 industry-sponsored, interventional oncology clinical programs (around 12,400 clinical trials), recent insights highlight ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

Insilico is among the companies that deploy AI and robotics in hopes of speeding up the time-consuming drug development process and improving its success rate. Insilico said its technology could ...

Wu Kaimin was worried her dissertation proposal might not be approved. Now, her research could fundamentally alter how ...

This designation facilitates interaction and communication with FDA throughout the drug development process, enables a rolling review ... As a result, it reduces the overall approval timeline, ...

Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic ...

The 6-month room temperature stability on this batch adds to the nine-month data accumulated on a previous batch produced by ...